cri-report.com China's Pharmaceutical Industry 2011

(prHWY.com) May 16, 2012 - Shanghai, China -- CRI-report: In 2011, the total investment amount of fixed assets in Chinese pharmaceutical industry was accumulated to CNY 261.536 billion, increasing by 45.5% YOY.

Since 2011, the increase speed of fixed asset investment in Chinese pharmaceutical industry has a rising trend on the whole, and the proportion of it is gradually enlarged. On one hand, the official implementation of the new version GMP promotes the sharp increase of capitals for the establishment of new plants and the purchase of equipment; on the other hand, some favorable factors such as the full operation of the new standards on the water pollutant emission of pharmaceutical industry, the successive acquisition of the initiative special funds for the important new drugs, the gradual increasing of the investment in the initiative new drugs from the enterprises and so on, spur the rapid increase speed of pharmaceutical industry investment. Currently, there have been 15 pharmaceutical enterprises approved by new version GMP, and many pharmaceutical enterprises are carrying out the reform according to new version GMP.

It is expected that the investment scale will still be enlarged in the future period.

To get more information: http://www.cri-report.com/biotechnology/966-brief-report-on-china-s-pharmaceutical-industry-2011.html

###